Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: A 7-year follow-up study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Schou, Morten ^a,b   Kjaergaard, Jesper ^a   Torp Pedersen, Christian ^c   Hassager, Christian ^a   Gustafsson, Finn ^a   Akkan, Dilek ^a   Moller, Jacob E ^a   Kober, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Estimated glomerular filtration rate; Heart failure; Mortality risk; Restrictive filling pattern

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; DECELERATION; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RESTRICTIVE LEFT VENTRICULAR FILLING PATTERN; SMOKING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSALITY; COMORBIDITY; DENMARK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84888800568     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-267     Document Type: Article

References (41)

1. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Hillege HL, Girbes AR, de Kam PJ, et al. Circulation 2000 102 203 210 (Pubitemid 30451778)
2. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Hillege HL, Nitsch D, Pfeffer MA, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators, et al. Circulation 2006 113 671 678
3. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. de Silva R, Nikitin NP, Witte KK, et al. Eur Heart J 2006 27 569 581
4. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW, J Am Coll Cardiol 2000 35 681 689 (Pubitemid 30167025)
5. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, ADHERE Scientific Advisory Committee and Investigators, J Card Fail 2007 6 422 430 (Pubitemid 47179911)
6. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Ahmed A, Rich MW, Sanders PW, et al. Am J Cardiol 2007 99 393 398
7. Atherosclerotic renovascular disease in chronic heart failure: should we intervene? de Silva R, Nikitin NP, Bhandari S, Nicholson A, Clark AL, Cleland JG, Eur Heart J 2005 26 1596 1605 (Pubitemid 41389689)
8. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P, J Am Coll Cardiol 2003 41 105 112 (Pubitemid 36044411)
9. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. de Silva R, Rigby AS, Witte KK, et al. Am J Cardiol 2006 98 391 398 (Pubitemid 44062453)
10. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JG, Am Heart J 2007 153 1048 1055 (Pubitemid 46809860)
11. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. Mullens W, Abrahams Z, Francis GS, et al. J Am Coll Cardiol 2009 53 589 596
12. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Cody RJ, Ljungman S, Covit AB, et al. Kidney Int 1988 34 361 367
13. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Assomull RG, Prasad SK, Lyne J, et al. J Am Coll Cardiol 2006 48 1977 1985 (Pubitemid 44738448)
14. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ, Am Heart J 2004 148 165 172 (Pubitemid 38900497)
15. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW, Circulation 2004 109 1004 1009 (Pubitemid 38282853)
16. Albuminuria in chronic heart failure: prevalence and prognostic importance. Jackson CE, Solomon SD, Gerstein HC, CHARM Investigators and Committees, et al. Lancet 2009 374 543 550
17. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL, J Am Coll Cardiol 2009 53 582 588
18. Confounding in epidemiological studies: why "independent" effects may not be all they seem. Smith GD, Phillips AN, BMJ 1992 305 757 759
19. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Foley RN, Parfrey PS, Harnett JD, et al. Kidney Int 1995 47 186 192
20. A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. Torp-Pedersen C, Køber L, Carlsen JE, et al. Eur J Heart Fail 2008 10 89 95
21. Prognostic importance of a short deceleration time in symptomatic congestive heart failure. Akkan D, Kjaergaard J, Møller JE, Hassager C, Torp-Pedersen C, Køber L, EchoCardiography and Heart Outcome Study (ECHOS) investigators, Eur J Heart Fail 2008 10 689 695
22. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL, Circulation 2006 114 1572 1580 (Pubitemid 44547427)
23. Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. Bruch C, Reinecke H, Rothenburger M, Scheld HH, Whalley GA, Stypmann J, Breithardt G, Wichter T, Gradaus R, J Am Soc Echocardiogr 2007 20 989 997 (Pubitemid 47102577)
24. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Aurigemma GP, Zile MR, Gaasch WH, Am Heart J 2004 148 12
25. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Packer M, Circulation 1990 81 78 86 (Pubitemid 20069398)
26. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Costanzo MR, Guglin ME, Saltzberg MT, UNLOAD Trial Investigators, et al. J Am Coll Cardiol 2007 49 675 683 (Pubitemid 46205043)
27. PROTECT Investigators and Committees. Massie BM, O'Connor CM, Metra M, et al. N Engl J Med 2010 363 1419 28
28. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Chow SL, Peng JT, Okamoto MP, Heywood JT, Ann Pharmacother 2007 41 556 561 (Pubitemid 46625477)
29. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure. de Silva R, Nikitin NP, Witte KK, et al. Eur J Heart Fail 2007 9 415 423 (Pubitemid 46463937)
30. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. Boerrigter G, Costello-Boerrigter LC, Abraham WT, et al. J Card Fail 2008 14 539 546
31. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. Jose P, Skali H, Anavekar N, Tomson C, et al. J Am Soc Nephrol 2006 17 2886 2891 (Pubitemid 44484679)
32. CATS randomized trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Hillege HL, van Gilst WH, van Veldhuisen DJ, et al. Eur Heart J 2003 24 412 420 (Pubitemid 36286184)
33. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. McMurray JJ, Ostergren J, Swedberg K, CHARM Investigators and Committees, et al. Lancet 2003 362 767 771 (Pubitemid 37093916)
34. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators, N Engl J Med 2001 345 1667 1675 (Pubitemid 33126822)
35. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. Pfeffer MA, McMurray JJ, Velazquez EJ, Valsartan in Acute Myocardial Infarction Trial Investigators, et al. N Engl J Med 2003 349 1893 1906 (Pubitemid 37409706)
36. High prevalence of microalbuminuria in chronic heart failure patients. van de Wal RM, Asselbergs FW, Plokker HW, et al. J Card Fail 2005 11 602 606 (Pubitemid 41463731)
37. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. Jose P, Tomson C, Skali H, et al. J Am Coll Cardiol 2006 47 1725 1727
38. Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: meta-analysis research group in echocardiography acute myocardial infarction. Møller JE, Whalley GA, Dini FL, Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators, et al. Circulation 2008 117 2591 2598
39. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators, Eur J Heart Fail 2008 10 786 792
40. Recalibrating the barometer: is it time to take a critical look at noninvasive approaches to measuring filling pressures? Solomon SD, Stevenson LW, Circulation 2009 119 13 15
41. Heart failure with preserved ejection fraction: dangerous, elusive, and difficult. Nielsen OW, Køber L, Torp-Pedersen C, Eur Heart J 2008 29 285 287 (Pubitemid 351197760)